Manocha Sachin, Lal Dushyant, Venkataraman Subramanian
Department of Pharmacology, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India, Vardhaman Mahaveer Open University, Department of Pharmacology, Vardhaman Mahavir Medical College, Safdarjung Hospital, New Delhi , India.
Department of Pharmacology, ESIC Dental College and Hospital, Rohini, New Delhi, India, Department of Pharmacology, ESIC Dental College and Hospital, New Delhi , India.
Arq Gastroenterol. 2016 Jan-Mar;53(1):36-43. doi: 10.1590/S0004-28032016000100008.
Nonsteroidal anti-inflammatory drugs induces gastric mucosal lesions because of its acidic properties. Ranitidine, an H2 receptor antagonist, has proved beneficial in patients with gastric ulcers.
The present study was performed to assess the effect of administering ranitidine in Nonsteroidal anti-inflammatory drugs (diclofenac, nimesulide) induced gastropathy, and their effect on the histopathology of stomach, kidney and liver.
Diclofenac, nimesulide, and ranitidine were administered in doses of 2, 4, and 6 mg/kg, p.o. once daily for 14 days, and their effect on gastric volume, acidity, mean ulcer number, and gastric pH. In addition, histopathological examination was also performed on sections of stomach, kidney and liver.
Following the administration of diclofenac or nimesulide, all the gastric parameters were significantly altered as well as the histopathology of stomach, liver and kidney. In the control group, the renal sections showed normal glomeruli with no thickening of glomerular basement membrane, while in diclofenac alone, nimesulide alone, and ranitidine with nimesulide groups, the thickening of glomerular basement membrane was observed. These alterations were observed to be reversed in the ranitidine with diclofenac group. In the sections from the liver, the control group showed anastomosing plates and cords of cuboidal hepatocytes with round well stained nuclei and abundant cytoplasm. In the ranitidine with diclofenac, and ranitidine with nimesulide groups, mild dilatation of sinusoids is seen coupled with prominence of central vein. In the diclofenac alone and nimesulide alone groups, the proximal and distal convoluted tubules show mild focal tubular necrosis. In the gastric sections, the control group showed several folds forming villi, and the epithelial lining surface of the mucosa. In the ranitidine with diclofenac, and ranitidine with nimesulide groups, the duodenum showed scattered inflammatory cells composed predominantly of lymphocytes. In diclofenac alone and nimesulide alone group, the sections from the gastric areas showed partial necrosis and mild chronic inflammation respectively.
The study, therefore, has provided therapeutic rationale towards simultaneous administration of H2 receptor blocker ranitidine with diclofenac to be more beneficial as compared to ranitidine with nimesulide, to minimise the gastric intolerance of diclofenac in long term treatment of inflammatory conditions.
非甾体抗炎药因其酸性特性可诱发胃黏膜损伤。雷尼替丁,一种H2受体拮抗剂,已被证明对胃溃疡患者有益。
本研究旨在评估雷尼替丁对非甾体抗炎药(双氯芬酸、尼美舒利)诱发的胃病的治疗效果,以及它们对胃、肾和肝脏组织病理学的影响。
双氯芬酸、尼美舒利和雷尼替丁分别以2、4和6mg/kg的剂量口服给药,每日一次,共14天,观察它们对胃容积、酸度、平均溃疡数和胃pH值的影响。此外,还对胃、肾和肝脏切片进行了组织病理学检查。
给予双氯芬酸或尼美舒利后,所有胃参数以及胃、肝脏和肾脏的组织病理学均发生了显著改变。对照组肾切片显示肾小球正常,肾小球基底膜无增厚,而在单独使用双氯芬酸组、单独使用尼美舒利组以及雷尼替丁与尼美舒利联合组中,观察到肾小球基底膜增厚。在雷尼替丁与双氯芬酸联合组中,这些改变有所逆转。肝脏切片中,对照组显示立方体细胞形成吻合的板层和索状结构,细胞核圆形且染色良好,细胞质丰富。在雷尼替丁与双氯芬酸联合组以及雷尼替丁与尼美舒利联合组中,可见轻度的肝血窦扩张以及中央静脉突出。在单独使用双氯芬酸组和单独使用尼美舒利组中,近端和远端曲管显示轻度局灶性肾小管坏死。胃切片中,对照组显示有多个形成绒毛的皱襞以及黏膜的上皮衬里表面。在雷尼替丁与双氯芬酸联合组以及雷尼替丁与尼美舒利联合组中,十二指肠显示散在的炎症细胞,主要由淋巴细胞组成。在单独使用双氯芬酸组和单独使用尼美舒利组中,胃区切片分别显示部分坏死和轻度慢性炎症。
因此,该研究为同时给予H2受体阻滞剂雷尼替丁和双氯芬酸提供了治疗依据,相较于雷尼替丁与尼美舒利联合,这样做在长期治疗炎症性疾病时能更有效地减轻双氯芬酸引起的胃部不耐受。